These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18956769)

  • 41. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.
    Punga VV; Jakubowiak WM; Danilova ID; Somova TR; Volchenkov GV; Kazionnyy BY; Nemtsova ES; Kiryanova EV; Kourbatova EV
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1309-12. PubMed ID: 19793439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis.
    Xu ZQ; Pupek K; Suling WJ; Enache L; Flavin MT
    Bioorg Med Chem; 2006 Jul; 14(13):4610-26. PubMed ID: 16513358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Investigation of rpsL and rrs gene region mutations in streptomycin resistant Mycobacterium tuberculosis complex isolates].
    Ulger M; Aslan G; Emekdaş G; Tezcan S; Serin MS
    Mikrobiyol Bul; 2009 Jan; 43(1):115-20. PubMed ID: 19334387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.
    Tabarsi P; Baghaei P; Jalali S; Farnia P; Chitsaz E; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Scand J Infect Dis; 2009; 41(1):10-3. PubMed ID: 19037820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis.
    Ahmad S; Al-Mutairi NM; Mokaddas E
    Indian J Exp Biol; 2009 Jun; 47(6):454-62. PubMed ID: 19634711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
    Chan ED; Strand MJ; Iseman MD
    Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
    Akbergenov R; Shcherbakov D; Matt T; Duscha S; Meyer M; Wilson DN; Böttger EC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4712-7. PubMed ID: 21768509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.
    Agrawal D; Udwadia ZF; Rodriguez C; Mehta A
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):79-83. PubMed ID: 19105883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].
    Toyota E; Kawabe Y; Yotsumoto H; Sakatani M; Tsuyuguchi K; Maekura R; Fujikawa K; Takashima T; Ogawa K; Yoshiyama T; Sugie T
    Kekkaku; 2008 Dec; 83(12):773-7. PubMed ID: 19172822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles.
    Karthikeyan SV; Perumal S; Shetty KA; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3006-9. PubMed ID: 19403307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel inhibitor of indole-3-glycerol phosphate synthase with activity against multidrug-resistant Mycobacterium tuberculosis.
    Shen H; Wang F; Zhang Y; Huang Q; Xu S; Hu H; Yue J; Wang H
    FEBS J; 2009 Jan; 276(1):144-54. PubMed ID: 19032598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Some regularities of an immune response in patients with pulmonary tuberculosis and drug-resistant Mycobacterium strains].
    Sakharova IIa; Ariél' BM; Knoring BE; Skvortsova LA; Vasil'eva GIu; Vishnevskiĭ BI; Pogodaeva SS
    Probl Tuberk Bolezn Legk; 2008; (12):22-7. PubMed ID: 19230184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoroquinolone resistance and Mycobacterium tuberculosis: CAP guidelines play an important role.
    Goyet S; Vlieghe E; Lim K; van Griensven J; Borand L; Thong P; Rammaert B; Marcy O; Tarantola A
    Int J Tuberc Lung Dis; 2014 May; 18(5):628-30. PubMed ID: 24903803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.